The pharmaceutical care of patients with type 2 diabetes mellitus.
OBJECTIVE
To evaluate the efficiency of pharmaceutical care on the control of clinical parameters, such as fasting glycaemia and glycosylated haemoglobin in patients with Type 2 Diabetes mellitus.


METHODS
This study was conducted at the Training and Community Health Centre of the College of Medicine of Ribeirao Preto, University of Sao Paulo, Brazil.


METHODS
A prospective and experimental study was conducted with 71 participants divided in two groups: (i) pharmaceutical care group (n=40), and (ii) the control group (n=31). The distribution of patients within these groups was made casually, and the patients were monitored for 12 months.


METHODS
Values for fasting glycaemia and glycosylated haemoglobin were collected.


RESULTS
Mean values of fasting glycaemia in the pharmaceutical care group were significantly reduced whilst a small reduction was detected in the control group at the same time. A significant reduction in the levels of glycosylated haemoglobin was detected in patients in the pharmaceutical care group, and an average increase was observed in the control group. Furthermore, the follow-up of the intervention group by a pharmacist contributed to the resolution of 62.7% of 142 drug therapy problems identified.


CONCLUSIONS
In Brazil, the information provided by a pharmacist to patients with Type 2 Diabetes mellitus increases compliance to treatment, solving or reducing the Drug Therapy Problem and, consequently, improving glycaemic control.
Borges
Anna Paula de Sá
AP
Department of Pharmaceutical Sciences, College of Pharmaceutical Science of Ribeirao Preto, University of Sao Paulo - USP, Avenida do Café, s/n, Ribeirao Preto, SP, 14040-903, Brazil. paulanasa@yahoo.com.br
Guidoni
Camilo Molino
CM
Ferreira
Lígia Domingues
LD
de Freitas
Osvaldo
O
Pereira
Leonardo Régis Leira
LR
D000368:Aged; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001938:Brazil / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D038321:Glycemic Index / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010593:Pharmaceutical Services; D010595:Pharmacists; D024382:Professional Role; D011446:Prospective Studies
D001786:Blood Glucose; D007004:Hypoglycemic Agents